Modeling motor neuron disease: the matter of time

Mandana Arbab, Susanne Baars, Niels Geijsen

Onderzoeksoutput: Bijdrage aan wetenschappelijk tijdschrift/periodieke uitgaveArtikelWetenschappelijkpeer review

25 Citaten (Scopus)


Stem cell technologies have created new opportunities to generate unlimited numbers of human neurons in the lab and study neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA). Although some disease hallmarks have been reported in patient-derived stem cell models, it is proving more difficult to recapitulate the full phenotypic extent of these disorders. The problem with these stem cell models lies in the disparity between the advanced age of onset of neurodegenerative disorders and the embryonic nature of the in vitro derived cell types. In this review we discuss experimental methods of in vitro aging of neural cell types as a means to elicit late-onset symptoms in induced pluripotent stem cell (iPSC) models of neurodegenerative disease.

Originele taal-2Engels
Pagina's (van-tot)642-52
Aantal pagina's11
TijdschriftTrends in Neurosciences
Nummer van het tijdschrift11
StatusGepubliceerd - nov. 2014


Duik in de onderzoeksthema's van 'Modeling motor neuron disease: the matter of time'. Samen vormen ze een unieke vingerafdruk.

Citeer dit